Riskpilot← Back to searchSign inGet full accessEA diagnostik konsult AB
ABActiveOrg 5592629553Ferievägen 57Medical specialists activities · NACE 8622Est. 20200 employees
Revenue 2024
SEK 322K
+22% vs 2023
EBITDA margin
37.6%
+21% vs 2023
Equity ratio
60.4%
Financial strength
Net profit 2024
SEK 83K
+170% vs 2023
| Revenue | SEK 322K | +22% |
| EBITDA | SEK 121K | +21% |
| Net profit | SEK 83K | +170% |
| Total assets | SEK 799K | +23% |
| Equity | SEK 482K | +21% |
| Employees | 0 | — |
Legal name
EA diagnostik konsult AB
Org number
5592629553
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
9 juli 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva konsultverksamhet inom patologi, medicinsk verksamhetsutveckling, medicinska försäkringsärenden, medicinteknisk utveckling, utbildning, ekonomi och management samt att äga och förvalta värdepapper och fastigheter och därmed förenlig verksamhet.
Address
Ferievägen 57
Email
andreas.andersson.hem@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 586 | 255 | 263 | 322 |
| Staff expenses | — | −126 | −122 | −141 |
| EBITDA | 419 | 87 | 100 | 121 |
| Depreciation & amort. | −0 | — | — | — |
| EBIT | 419 | 87 | 100 | 121 |
| Net financials | — | 0 | −1 | 19 |
| Profit before tax | 313 | 65 | 99 | 106 |
| Tax | −68 | 34 | −69 | −23 |
| Net profit | 245 | 99 | 31 | 83 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 508 | 569 | 652 | 799 |
| Equity | 270 | 369 | 399 | 482 |
| Long-term debt | 0 | — | — | — |
| Short-term debt | 132 | 73 | 124 | 155 |
| Total debt | 132 | 73 | 124 | 155 |
EBITDA margin
37.6%
This company
15.8%
Market median
+138% vs market
20212024
Equity ratio
60.4%
This company
38.2%
Market median
+58% vs market
20212024
Return on equity
17.2%
This company
18.4%
Market median
+7% vs market
20212024
Net profit margin
25.7%
This company
8.1%
Market median
+217% vs market
20212024
Asset turnover
0.40×
This company
1.12×
Market median
-64% vs market
20212024
Debt / equity
0.66×
This company
0.62×
Market median
+6% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2025 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of EA diagnostik konsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Andreas Andersson | Deputy Board Member | 0 companies |
| Karin Emilia Andersson | Board of Directors | 0 companies |
| Anne-Charlotte Margaretha Leffler | Deputy Board Member | 0 companies |